In addition, numerous epigenomic-related gene mutations occur in ccRCC (e.g., PBRM1, SETD2, KDM5C, BAP1 deletions or mutations) which suggests that dysregulation of chromatin remodeling plays an important role in ccRCC [18]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.